137 related articles for article (PubMed ID: 8516734)
21. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
[TBL] [Abstract][Full Text] [Related]
22. Clinico-pathologic features of chronic myeloid leukemia and risk stratification according to Sokal score.
Syed NN; Usman M; Khaliq G; Adil SN; Khurshid M
J Coll Physicians Surg Pak; 2006 May; 16(5):336-9. PubMed ID: 16756777
[TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of allogeneic bone marrow transplantation in patients with acute leukemia in complete remission and in patients with chronic myeloid leukemia during the chronic phase].
Liubimova LS; Savchenko VG; Mendeleeva LP; Kliasova GA; Gribanova EO; Demidova IA; Gal'tseva IV; Kuz'mina LA; Momotiuk KS; Kuliev RG
Ter Arkh; 1999; 71(7):27-32. PubMed ID: 10481864
[TBL] [Abstract][Full Text] [Related]
24. [Philadelphia chromosome-positive chronic myeloid leukemia in the elderly: presenting features, natural history and survival].
Hernández-Boluda JC; Cervantes F; Camós M; Costa D; Rafel M; Montserrat E
Med Clin (Barc); 1999 May; 112(15):565-7. PubMed ID: 10365381
[TBL] [Abstract][Full Text] [Related]
25. [Chronic myeloid leukemia beginning as thrombocythemia. Analysis of 5 cases].
Cervantes F; Alcorta I; Bosch F; Vives-Corrons JL; Rozman C
Sangre (Barc); 1992 Feb; 37(1):1-3. PubMed ID: 1585231
[TBL] [Abstract][Full Text] [Related]
26. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
Sloand E; Childs RW; Solomon S; Greene A; Young NS; Barrett AJ
Bone Marrow Transplant; 2003 Nov; 32(9):897-901. PubMed ID: 14561990
[TBL] [Abstract][Full Text] [Related]
27. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
Mackinnon S; Barnett L; Heller G
Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
[TBL] [Abstract][Full Text] [Related]
28. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
[TBL] [Abstract][Full Text] [Related]
29. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
31. Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase.
Schattenberg A; Preijers F; Mensink E; Bär B; Schaap N; Geurts van Kessel A; van der Maazen R; de Witte T
Bone Marrow Transplant; 1997 Jun; 19(12):1205-12. PubMed ID: 9208114
[TBL] [Abstract][Full Text] [Related]
32. The changing profile of Ph-positive chronic myeloid leukemia at presentation: possible impact of earlier diagnosis on survival.
Cervantes F; Hernández-Boluda JC; Ferrer A; Cid J; Montserrat E
Haematologica; 1999 Apr; 84(4):324-7. PubMed ID: 10190946
[TBL] [Abstract][Full Text] [Related]
33. Post-transplant outcome in chronic myeloid leukaemia.
Raza S; Ullah K; Ahmed P; Khan B; Kamal MK
J Coll Physicians Surg Pak; 2008 Oct; 18(10):615-9. PubMed ID: 18940118
[TBL] [Abstract][Full Text] [Related]
34. Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy.
Hasford J; Pfirrmann M; Hehlmann R; Baccarani M; Guilhot F; Mahon FX; Kluin-Nelemans HC; Ohnishi K; Thaler J; Steegmann JL;
Semin Hematol; 2003 Jan; 40(1):4-12. PubMed ID: 12563607
[TBL] [Abstract][Full Text] [Related]
35. Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients.
Cervantes F; Hernández-Boluda JC; Steegmann JL; Conde E; Alvarez-Larrán A; López-Jiménez J; Osorio S; Villalón L; Camós M; García-Conde J; Odriozola J
Haematologica; 2003 Oct; 88(10):1117-22. PubMed ID: 14555307
[TBL] [Abstract][Full Text] [Related]
36. Related donor marrow transplant for chronic myeloid leukemia: patient characteristics predictive of outcome.
Enright H; Daniels K; Arthur DC; Dusenbery KE; Kersey JH; Kim T; Miller WJ; Ramsay NK; Vercellotti GM; Weisdorf DJ; McGlave PB
Bone Marrow Transplant; 1996 Apr; 17(4):537-42. PubMed ID: 8722351
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
[TBL] [Abstract][Full Text] [Related]
38. Autologous stem cell transplantation in chronic myeloid leukemia: a single center experience.
Pigneux A; Faberes C; Boiron JM; Mahon FX; Cony-Makhoul P; Agape P; Lounici A; Bernard P; Bilhou-Nabera C; Bouzgarrou R; Marit G; Reiffers J
Bone Marrow Transplant; 1999 Aug; 24(3):265-70. PubMed ID: 10455364
[TBL] [Abstract][Full Text] [Related]
39. [STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia].
Meng FY; Zheng WY; Liu XL; Xu B; Song LL; Zhang Y; Huang F
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1149-50. PubMed ID: 14625174
[TBL] [Abstract][Full Text] [Related]
40. [Multivariate analysis of prognostic factors in Philadelphia chromosome-positive chronic granulocytic leukemia].
Hao C; Wang Y; Li Q; Liu B; Qian L
Zhonghua Xue Ye Xue Za Zhi; 2001 Jan; 22(1):5-8. PubMed ID: 11877041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
